Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Accounts Payables (2017 - 2020)

enVVeno Medical has reported Accounts Payables over the past 4 years, most recently at $974229.0 for Q3 2020.

  • Quarterly results put Accounts Payables at $974229.0 for Q3 2020, down 19.57% from a year ago — trailing twelve months through Sep 2020 was $974229.0 (down 19.57% YoY), and the annual figure for FY2019 was $1.2 million, up 13.38%.
  • Accounts Payables for Q3 2020 was $974229.0 at enVVeno Medical, down from $1.6 million in the prior quarter.
  • Over the last five years, Accounts Payables for NVNO hit a ceiling of $1.6 million in Q2 2020 and a floor of $974229.0 in Q3 2020.
  • Median Accounts Payables over the past 4 years was $1.2 million (2019), compared with a mean of $1.3 million.
  • Biggest five-year swings in Accounts Payables: decreased 25.78% in 2018 and later surged 30.95% in 2020.
  • enVVeno Medical's Accounts Payables stood at $1.5 million in 2017, then decreased by 25.78% to $1.1 million in 2018, then grew by 13.38% to $1.2 million in 2019, then dropped by 20.22% to $974229.0 in 2020.
  • The last three reported values for Accounts Payables were $974229.0 (Q3 2020), $1.6 million (Q2 2020), and $1.4 million (Q1 2020) per Business Quant data.